Bruker Corp (BRKR) stock

BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 6/30264% above fair value

$57.07−4.93 (-7.95%)

Close on Oct 30, 2026Market cap $8.85BP/E –Yield –

Earnings

Bruker's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 2, 2026

Q3 FY2026 · estimated, before the open

Revenue, Q2 FY2026

$838.50M

+5.2% on a year earlier

non-GAAP diluted earnings per share (EPS), Q2 FY2026

$0.49

$0.32 a year earlier

Latest guidance

Lowered

Aug 4, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Bruker's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2026ended Sep 30, 2026	Nov 2, 2026Expected	–	–	–	–	–
Q2 FY2026ended Jun 30, 2026	Aug 4, 2026before the open	$838.50M	+5.2%	-$0.41	$0.49	Release
Q1 FY2026ended Mar 31, 2026	May 6, 2026before the open	$823.40M	+2.7%	$0.02	$0.31	Release
Q4 FY2025ended Dec 31, 2025	Feb 12, 2026before the open	$977.20M	-0.2%	$0.10	$0.59	Release
Q3 FY2025ended Sep 30, 2025	Nov 3, 2025before the open	$860.50M	-0.5%	-$0.41	$0.45	Release
Q2 FY2025ended Jun 30, 2025	Aug 4, 2025before the open	$797.40M	-0.4%	$0.05	$0.32	Release
Q1 FY2025ended Mar 31, 2025	May 7, 2025before the open	$801.40M	+11.0%	$0.11	$0.47	Release
Q4 FY2024ended Dec 31, 2024	Feb 13, 2025before the open	$979.60M	+14.6%	$0.09	$0.76	Release
Q3 FY2024ended Sep 30, 2024	Nov 5, 2024before the open	$864.40M	+16.4%	$0.27	$0.60	Release
Q2 FY2024ended Jun 30, 2024	Aug 6, 2024before the open	$800.70M	+17.4%	$0.05	$0.52	Release
Q1 FY2024ended Mar 31, 2024	May 2, 2024before the open	$721.70M	+5.3%	$0.35	$0.53	Release
Q4 FY2023ended Dec 31, 2023	Feb 13, 2024before the open	$854.50M	+20.6%	$1.41	$0.70	Release
Q3 FY2023ended Sep 30, 2023	Nov 2, 2023before the open	$742.80M	+16.3%	$0.60	$0.74	Release
Q2 FY2023ended Jun 30, 2023	Aug 3, 2023before the open	$681.90M	+15.9%	$0.39	$0.50	Release
Q1 FY2023ended Mar 31, 2023	May 4, 2023before the open	$685.30M	+15.2%	$0.52	$0.64	Release
Q4 FY2022ended Dec 31, 2022	Feb 9, 2023before the open	$708.40M	–	$0.66	$0.74	Release
Q3 FY2022ended Sep 30, 2022	Nov 3, 2022before the open	$638.90M	+4.9%	$0.59	$0.66	Release
Q2 FY2022ended Jun 30, 2022	Aug 3, 2022during market hours	$588.40M	–	$0.33	$0.45	Release
Q1 FY2022ended Mar 31, 2022	May 4, 2022before the open	$595.00M	–	$0.41	$0.49	Release
Q4 FY2021ended Dec 31, 2021	Feb 11, 2022before the open	–	–	–	$0.59	Release
Q3 FY2021ended Sep 30, 2021	Nov 1, 2021during market hours	$608.90M	–	$0.57	$0.63	Release
Q2 FY2021ended Jun 30, 2021	Aug 2, 2021during market hours	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 13, 2021during market hours	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 16, 2021before the open	–	–	–	–	Release
Q3 FY2020ended Sep 30, 2020	Nov 2, 2020during market hours	–	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Jul 22, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Bruker's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Organic revenue growthnon-GAAP	FY2026	+1% – +2%	–	New	Feb 12, 2026
revenues	FY2026	$3.57B – $3.60B	–	New	Feb 12, 2026
Revenues	FY2026	$3.54B – $3.57B	$3.57B – $3.60B	Lowered	Aug 4, 2026
non-GAAP EPSnon-GAAP	FY2026	$2.10 – $2.15	–	New	Feb 12, 2026
Non-GAAP EPSnon-GAAP	FY2026	$2.10 – $2.15	$2.10 – $2.15	Reaffirmed	Aug 4, 2026

Guidance vs results

The last range Bruker gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	non-GAAP EPS	$1.85 – $1.90	$1.83Σ4Q	Below range
FY2025	Revenue	$3.41B – $3.44B	$3.44BΣ4Q	Within range
FY2025	Revenue growth	+1% – +2%	+2.08%Σ4Q	Above range

Guidance history

Every forecast Bruker put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 4, 2026	Non-GAAP EPS	FY2026	$2.10 – $2.15	Reaffirmed
Aug 4, 2026	Revenues	FY2026	$3.54B – $3.57B	Lowered
May 6, 2026	non-GAAP EPS	FY2026	$2.10 – $2.15	New
May 6, 2026	revenues	FY2026	$3.57B – $3.60B	New
Feb 12, 2026	non-GAAP EPS	FY2026	$2.10 – $2.15	New
Feb 12, 2026	Organic revenue growth	FY2026	+1% – +2%	New
Feb 12, 2026	revenues	FY2026	$3.57B – $3.60B	New
Nov 3, 2025	non-GAAP EPS	FY2025	$1.85 – $1.90	New
Nov 3, 2025	reported revenue growth	FY2025	+1% – +2%	New
Nov 3, 2025	Organic revenue decline	FY2025	-5% – -4%	New
Nov 3, 2025	M&A revenue growth contribution	FY2025	+3.5%	Raised
Nov 3, 2025	Foreign currency translation revenue tailwind	FY2025	+2.5%	Lowered
Nov 3, 2025	revenues	FY2025	$3.41B – $3.44B	New
Aug 4, 2025	non-GAAP EPS	FY2025	$1.95 – $2.05	Lowered
Aug 4, 2025	revenues	FY2025	$3.43B – $3.50B	New
May 7, 2025	non-GAAP EPS	FY2025	$2.40 – $2.48	Lowered
May 7, 2025	revenues	FY2025	$3.48B – $3.55B	Raised
Feb 13, 2025	non-GAAP EPS	FY2025	$2.67 – $2.72	New
Feb 13, 2025	revenues	FY2025	$3.47B – $3.54B	New
Nov 5, 2024	non-GAAP EPS	FY2024	$2.36 – $2.41	Lowered
Nov 5, 2024	reported revenue growth	FY2024	+12.5% – +13.5%	New
Nov 5, 2024	Organic revenue growth	FY2024	+3% – +4%	Lowered
Nov 5, 2024	Contribution from M&A	FY2024	+9.5%	Raised
Nov 5, 2024	CER revenue growth	FY2024	+13%	Raised
Nov 5, 2024	Revenue	FY2024	$3.34B – $3.37B	Lowered
Aug 6, 2024	non-GAAP EPS	FY2024	$2.59 – $2.64	Lowered
Aug 6, 2024	revenues	FY2024	$3.38B – $3.44B	Raised
May 2, 2024	non-GAAP EPS	FY2024	$2.79 – $2.84	Raised
May 2, 2024	Constant exchange rate (CER) revenue growth	FY2024	+12% – +14%	Raised
May 2, 2024	revenues	FY2024	$3.29B – $3.35B	New
May 2, 2024	Organic revenue growth	FY2024	+5% – +7%	Reaffirmed
Feb 13, 2024	non-GAAP EPS	FY2024	$2.71 – $2.76	New
Feb 13, 2024	Constant exchange rate (CER) revenue growth	FY2024	+8% – +10%	New
Feb 13, 2024	revenues	FY2024	$3.23B – $3.29B	New
Feb 13, 2024	Organic revenue growth	FY2024	+5% – +7%	New
Nov 2, 2023	non-GAAP EPS	FY2023	$2.48 – $2.53	Lowered
Nov 2, 2023	revenue	FY2023	$2.88B – $2.91B	Raised
Aug 3, 2023	non-GAAP EPS	FY2023	$2.55 – $2.60	Reaffirmed
Aug 3, 2023	revenue	FY2023	$2.85B – $2.90B	Raised
Aug 3, 2023	organic revenue growth	FY2023	+9.5% – +11.5%	Raised
May 4, 2023	non-GAAP EPS	FY2023	$2.55 – $2.60	Raised
May 4, 2023	organic revenue growth	FY2023	+9% – +11%	Raised
May 4, 2023	revenue	FY2023	$2.83B – $2.88B	New
Feb 9, 2023	non-GAAP EPS	FY2023	$2.52 – $2.57	New
Feb 9, 2023	R&D expenses	FY2023	10%	New
Feb 9, 2023	revenue	FY2023	$2.81B – $2.86B	New
Feb 9, 2023	organic revenue growth	FY2023	+8% – +10%	New
Nov 3, 2022	non-GAAP EPS	FY2022	$2.29 – $2.33	Reaffirmed
Nov 3, 2022	non-GAAP operating margin expansion	FY2022	60 – 90	Raised
Nov 3, 2022	organic revenue growth	FY2022	+8% – +10%	Raised
Nov 3, 2022	reported revenue growth	FY2022	+1.5% – +3.5%	Lowered
Aug 3, 2022	non-GAAP EPS	FY2022	$2.29 – $2.33	Reaffirmed
Aug 3, 2022	non-GAAP operating margin expansion	FY2022	30 – 60	Reaffirmed
Aug 3, 2022	reported revenue growth	FY2022	+2.5% – +4.5%	Lowered
Aug 3, 2022	organic growth	FY2022	+7% – +9%	Reaffirmed
May 4, 2022	non-GAAP EPS	FY2022	$2.29 – $2.33	New
May 4, 2022	non-GAAP operating margin expansion	FY2022	30 – 60	New
May 4, 2022	reported revenue growth	FY2022	+5% – +7%	New
May 4, 2022	organic growth	FY2022	+7% – +9%	Raised
Feb 11, 2022	organic revenue growth	FY2022	+6% – +8%	New
Feb 11, 2022	revenue growth	FY2022	+5% – +7%	New
Nov 1, 2021	Non-GAAP EPS	FY2021	$2.05 – $2.09	New
Nov 1, 2021	Non-GAAP operating margin	FY2021	19.5% – 20%	New
Nov 1, 2021	Organic revenue growth	FY2021	+16.5% – +17.5%	New
Nov 1, 2021	Reported revenue growth	FY2021	+19.5% – +20.5%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.